X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30893) 30893
Newsletter (707) 707
Newspaper Article (250) 250
Dissertation (49) 49
Magazine Article (47) 47
Book Chapter (29) 29
Publication (10) 10
Transcript (5) 5
Book Review (2) 2
Conference Proceeding (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18017) 18017
dexamethasone (16471) 16471
male (14836) 14836
female (13451) 13451
dexamethasone - administration & dosage (10204) 10204
animals (10112) 10112
adult (7420) 7420
middle aged (7390) 7390
dexamethasone - pharmacology (6624) 6624
aged (5322) 5322
rats (4715) 4715
dexamethasone - therapeutic use (4604) 4604
treatment outcome (3863) 3863
oncology (3718) 3718
hematology (2886) 2886
steroids (2865) 2865
antineoplastic combined chemotherapy protocols - therapeutic use (2864) 2864
pharmacology & pharmacy (2666) 2666
mice (2655) 2655
corticosteroids (2650) 2650
glucocorticoids - administration & dosage (2608) 2608
glucocorticoids (2518) 2518
therapy (2289) 2289
adolescent (2286) 2286
multiple myeloma (2248) 2248
care and treatment (2214) 2214
research (2209) 2209
time factors (2165) 2165
dexamethasone - adverse effects (2121) 2121
dose-response relationship, drug (2076) 2076
multiple myeloma - drug therapy (2066) 2066
chemotherapy (2055) 2055
endocrinology & metabolism (2015) 2015
analysis (1986) 1986
glucocorticoids - pharmacology (1940) 1940
drug therapy, combination (1790) 1790
pregnancy (1740) 1740
dosage and administration (1715) 1715
surgery (1710) 1710
expression (1707) 1707
child (1693) 1693
bortezomib (1674) 1674
cancer (1665) 1665
prospective studies (1645) 1645
aged, 80 and over (1626) 1626
inflammation (1626) 1626
drug therapy (1621) 1621
pediatrics (1621) 1621
anti-inflammatory agents - administration & dosage (1598) 1598
medicine & public health (1592) 1592
retrospective studies (1584) 1584
neurosciences (1521) 1521
health aspects (1470) 1470
hydrocortisone - blood (1457) 1457
drug administration schedule (1393) 1393
ophthalmology (1371) 1371
follow-up studies (1359) 1359
rats, sprague-dawley (1309) 1309
antineoplastic combined chemotherapy protocols - adverse effects (1303) 1303
double-blind method (1300) 1300
anti-inflammatory agents - therapeutic use (1287) 1287
glucocorticoids - therapeutic use (1285) 1285
disease models, animal (1263) 1263
children (1212) 1212
prevention (1170) 1170
risk factors (1166) 1166
rats, wistar (1160) 1160
central nervous system depressants (1151) 1151
immunology (1150) 1150
child, preschool (1144) 1144
abridged index medicus (1084) 1084
infant, newborn (1079) 1079
cyclophosphamide - administration & dosage (1071) 1071
clinical trials (1052) 1052
medicine, general & internal (1046) 1046
antineoplastic combined chemotherapy protocols - administration & dosage (1027) 1027
patients (1018) 1018
administration, oral (1015) 1015
young adult (1015) 1015
double-blind (1009) 1009
vincristine - administration & dosage (998) 998
cells (996) 996
cells, cultured (991) 991
doxorubicin - administration & dosage (991) 991
biochemistry & molecular biology (990) 990
survival (988) 988
efficacy (947) 947
thalidomide - administration & dosage (942) 942
anti-inflammatory agents - pharmacology (933) 933
infant (929) 929
administration, topical (928) 928
apoptosis (928) 928
prognosis (915) 915
recurrence (903) 903
lenalidomide (886) 886
medicine, research & experimental (866) 866
nausea (863) 863
cortisol (862) 862
drugs (857) 857
diagnosis (856) 856
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30455) 30455
Japanese (565) 565
German (415) 415
French (270) 270
Chinese (238) 238
Russian (188) 188
Spanish (158) 158
Portuguese (102) 102
Polish (88) 88
Italian (66) 66
Czech (38) 38
Dutch (21) 21
Hungarian (19) 19
Korean (16) 16
Turkish (15) 15
Danish (13) 13
Persian (13) 13
Swedish (11) 11
Norwegian (9) 9
Romanian (8) 8
Ukrainian (8) 8
Bulgarian (6) 6
Serbian (5) 5
Croatian (4) 4
Hebrew (4) 4
Arabic (2) 2
Bosnian (2) 2
Finnish (2) 2
Indonesian (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, p. CD002311
.... Local administration of corticosteroids via inhalation might be an effective and safe alternative... 
Budesonide | Pneumonia | Respiratory Disorders | Dexamethasone | Glucocorticoids | Administration, Inhalation | Bronchopulmonary Dysplasia | Fluticasone | Randomized Controlled Trials as Topic | Beclomethasone | Neonatal care | Infant, Premature | Child health | Anti‐Inflammatory Agents | Fluocinolone Acetonide | Bronchopulmonary Dysplasia (Chronic Lung Disease) | Medicine General & Introductory Medical Sciences | CONTROLLED-TRIAL | INHALED GLUCOCORTICOID THERAPY | LOW-BIRTH-WEIGHT | Humans | PREMATURE-INFANTS | Infant | CHRONIC LUNG-DISEASE | MEDICINE, GENERAL & INTERNAL | Anti-Inflammatory Agents [administration & dosage] | Dexamethasone [administration & dosage] | Bronchopulmonary Dysplasia [etiology | Glucocorticoids [administration & dosage] | drug therapy | Budesonide [administration & dosage] | prevention& control | ADRENAL-FUNCTION | BECLOMETHASONE DIPROPIONATE | Beclomethasone [administration & dosage] | Pneumonia [complications | METERED-DOSE INHALER | Newborn | Androstadienes [administration & dosage] | FLUTICASONE PROPIONATE | analogs & derivatives | DOUBLE-BLIND | Fluocinolone Acetonide [administration & dosage | Beclomethasone - administration & dosage | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Dexamethasone - administration & dosage | Fluocinolone Acetonide - analogs & derivatives | Bronchopulmonary Dysplasia - prevention & control | Pneumonia - drug therapy | Fluticasone - administration & dosage | Pneumonia - complications | Anti-Inflammatory Agents - administration & dosage | Budesonide - administration & dosage | Bronchopulmonary Dysplasia - etiology | Infant, Newborn
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2020, Issue 9, p. CD004454
Journal Article
British journal of cancer, ISSN 1532-1827, 2014, Volume 111, Issue 6, pp. 1072 - 1079
Background: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devastating complication; the optimal prophylactic strategy... 
cytarabine | INTERMEDIATE-GRADE | FOLLOW-UP | diffuse large B-cell lymphoma | methotrexate intrathecal | CHEMOTHERAPY | central nervous system | RELAPSE | central nervous system prophylaxis | ONCOLOGY | STANDARD CHOP | NON-HODGKINS-LYMPHOMA | CNS PROPHYLAXIS | AGGRESSIVE LYMPHOMA | RITUXIMAB ERA | ELDERLY-PATIENTS | Recurrence | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Central Nervous System Neoplasms - secondary | Young Adult | Central Nervous System Neoplasms - prevention & control | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Acute Kidney Injury - chemically induced | Retrospective Studies | Doxorubicin - administration & dosage | Injections, Spinal | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Rituximab | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Administration, Intravenous | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Aged | intrathecal | methotrexate | Clinical Study
Journal Article
Blood, ISSN 1528-0020, 2013, Volume 122, Issue 7, pp. 1214 - 1221
Detection of MRD by real-time quantitative PCR and flow cytometry is an important predictor of outcome in patients with Ph+ ALL. 
ADULT PATIENTS | HYPER-CVAD | GENE REARRANGEMENTS | STANDARD-RISK | QUANTIFICATION | ACUTE LYMPHOBLASTIC-LEUKEMIA | FLOW-CYTOMETRY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | CLINICAL-SIGNIFICANCE | Piperazines - administration & dosage | Cyclophosphamide - administration & dosage | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Thiazoles - administration & dosage | Neoplasm Recurrence, Local - mortality | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Benzamides - administration & dosage | Flow Cytometry | Neoplasm, Residual - diagnosis | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neoplasm, Residual - mortality | Philadelphia Chromosome | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | Dasatinib | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Pyrimidines - administration & dosage | RNA, Messenger - genetics | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | Imatinib Mesylate | Remission Induction | Cytarabine - administration & dosage | Neoplasm, Residual - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | Immunoglobulin Heavy Chains - genetics | Lymphoid Neoplasia
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2015, Volume 2015, Issue 8, p. CD001430
Background Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost... 
Acute Disease | Dexamethasone | Injections, Intravenous | Glucocorticoids | Administration, Oral | Optic Neuritis | Prednisone | Methylprednisolone | Visual Acuity | Randomized Controlled Trials as Topic | Optic nerve disease | Anti‐Inflammatory Agents | Eyes & vision | Medicine General & Introductory Medical Sciences | Contrast Sensitivity | TREATMENT-TRIAL | Humans | Male | FOLLOW-UP | RECOVERY | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE METHYLPREDNISOLONE | MULTIPLE-SCLEROSIS | Female | Anti-Inflammatory Agents [administration & dosage; therapeutic use] | VISUAL-FIELD PROFILE | Prednisone [administration & dosage; therapeutic use] | Methylprednisolone [administration & dosage; therapeutic use] | Dexamethasone [administration & dosage; therapeutic use] | Contrast Sensitivity [drug effects] | Optic Neuritis [drug therapy] | INJECTION | EXPERIENCE | Visual Acuity [drug effects] | Glucocorticoids [administration & dosage; therapeutic use] | FUNCTION QUESTIONNAIRE | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Methylprednisolone - therapeutic use | Dexamethasone - therapeutic use | Visual Acuity - drug effects | Optic Neuritis - drug therapy | Contrast Sensitivity - drug effects | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IDARUBICIN | THERAPY | DOSE ARA-C | PEDIATRIC-PATIENTS | SENSITIVITY | RISK | CHILDHOOD LEUKEMIA | EXPERIENCE | ACCELERATED APPROVAL | ONCOLOGY GROUP | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Databases | Cytogenetics | Cancer therapies | Cancer | Ovarian cancer
Journal Article
Blood, ISSN 1528-0020, 2012, Volume 119, Issue 20, pp. 4619 - 4624
Approximately 5-10% of diffuse large B-cell lymphomas (DLBCL) harbor a 8q24/MYC rearrangement (MYC+). We determined the prognostic significance of MYC... 
REARRANGEMENT | IMPACT | POOR-PROGNOSIS | T(14/18) | IN-SITU HYBRIDIZATION | CLASSIFICATION | HEMATOLOGY | EXPRESSION | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Podophyllotoxin - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cisplatin - administration & dosage | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Melphalan - adverse effects | Immunotherapy | Treatment Failure | Podophyllotoxin - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Carmustine - adverse effects | Genes, myc - physiology | Dexamethasone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Ifosfamide - adverse effects | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Melphalan - administration & dosage | Ifosfamide - administration & dosage | Cisplatin - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Carmustine - administration & dosage | Life Sciences | Biochemistry, Molecular Biology | Lymphoma, Large B-Cell, Diffuse | Podophyllotoxin | methods | Genes, myc | Cytarabine | genetics | administration & dosage | Melphalan | Antibodies, Monoclonal, Murine-Derived | Dexamethasone | drug therapy | Ifosfamide | Carmustine | therapy | Antineoplastic Combined Chemotherapy Protocols | Etoposide | physiology | Hematopoietic Stem Cell Transplantation | Cisplatin | adverse effects | mortality
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article